Clinical trial

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

NCT03675412

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2018-12-30

PhaseNA

Study timeline

Study start (actual)2018-12-30Date precision: day

Registry last updated2026-08-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucoma, Primary Open Angleunresolved

Interventions

Caffeine tabletDIETARY_SUPPLEMENT

Sponsors & collaborators

Wills Eyelead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03675412 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.